Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuyuki Horita

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
Cancers|January 8, 2023
Tumor Response, Disease Control, and Progression-Free Survival as Surrogate Endpoints in Trials Evaluating Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Study- and Patient-Level AnalysesNobuyuki Horita
European Journal of Cancer (Oxford, England : 1990)|March 1, 2022
Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in JapanNobuyuki Horita
Respiratory Care|November 22, 2013
Depression in Japanese patients with COPD: a cross-sectional study--replyNobuyuki Horita,
Meta Gene|June 5, 2015
Genetic model selection for a case-control study and a meta-analysisNobuyuki Horita, Takeshi Kaneko
Chest|April 9, 2016
Adjunctive Systemic Corticosteroids for Severe Community-Acquired PneumoniaNobuyuki Horita, Takeshi Kaneko
Translational Oncology|May 22, 2022
The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastasesTakeshi Fukumoto, Nobuyuki Horita
Journal of Medical Virology|October 18, 2022
Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemicNobuyuki Horita, Takeshi Fukumoto
The Lancet. Psychiatry|June 23, 2023
COVID-19, young people, and suicidal behaviourNobuyuki Horita, Sho Moriguchi
American Journal of Respiratory and Critical Care Medicine|April 2, 2020
Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a TrialNobuyuki Horita, Kaneko Takeshi
International Journal of Chronic Obstructive Pulmonary Disease|May 12, 2015
Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in JapanNobuyuki Horita, Takeshi Kaneko
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
Cancers|January 8, 2023
Tumor Response, Disease Control, and Progression-Free Survival as Surrogate Endpoints in Trials Evaluating Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Study- and Patient-Level AnalysesNobuyuki Horita
European Journal of Cancer (Oxford, England : 1990)|March 1, 2022
Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in JapanNobuyuki Horita
Respiratory Care|November 22, 2013
Depression in Japanese patients with COPD: a cross-sectional study--replyNobuyuki Horita,
Meta Gene|June 5, 2015
Genetic model selection for a case-control study and a meta-analysisNobuyuki Horita, Takeshi Kaneko
Chest|April 9, 2016
Adjunctive Systemic Corticosteroids for Severe Community-Acquired PneumoniaNobuyuki Horita, Takeshi Kaneko
Translational Oncology|May 22, 2022
The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastasesTakeshi Fukumoto, Nobuyuki Horita
Journal of Medical Virology|October 18, 2022
Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemicNobuyuki Horita, Takeshi Fukumoto
The Lancet. Psychiatry|June 23, 2023
COVID-19, young people, and suicidal behaviourNobuyuki Horita, Sho Moriguchi
American Journal of Respiratory and Critical Care Medicine|April 2, 2020
Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a TrialNobuyuki Horita, Kaneko Takeshi
International Journal of Chronic Obstructive Pulmonary Disease|May 12, 2015
Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in JapanNobuyuki Horita, Takeshi Kaneko
Pageof 26